Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post- Approval Surveillance Study To Evaluate Real World Clinical Outcomes Data for the PROMUS™ Element™ Coronary Stent System in Unselected Patients in Routine Clinical Practice

NCT01148329 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01148329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01148329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post- Approval Surveillance Study To Evaluate Real World Clinical Outcomes Data for the PROMUS™ Element™ Coronary Stent System in Unselected Patients in Routine Clinical Practice
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2016
Enrollment
1,010 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease